These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4205281)

  • 1. [Factors influencing the minimal inhibitory concentration of rifampicin for Mycobacterium tuberculosis (author's transl)].
    Tamura M; Yamazaki A; Tamura T; Takano S
    Kekkaku; 1973 Oct; 48(10):463-71. PubMed ID: 4205281
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the antituberculous activities of rifampicin (REP) and the period of exposure in vitro (author's transl)].
    Uratsuji Y
    Bull Chest Dis Res Inst Kyoto Univ; 1978 Mar; 10(1-2):1-19. PubMed ID: 99200
    [No Abstract]   [Full Text] [Related]  

  • 3. [The sensitivity of Mycobacterium tuberculosis to rifampicin and its clinical effectiveness (author's transl)].
    Chen HL
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1980 Feb; 3(2):104-5. PubMed ID: 6774865
    [No Abstract]   [Full Text] [Related]  

  • 4. [The clinical significance of the critical drug concentration of rifampicin. Report 1. Studies on the MIC of rifampicin to tubercle bacilli isolated from the rifampicin untreated patients using 1% Ogawa medium (author's transl)].
    Baba H; Azuma Y
    Kekkaku; 1976 Jan; 51(1):1-5. PubMed ID: 815708
    [No Abstract]   [Full Text] [Related]  

  • 5. [Action of ethambutol and rifampicin on the phagocyted mycobacterium by alveolar macrophage (author's transl)].
    Stoica E
    Acta Tuberc Pneumol Belg; 1972; 63(6):501-9. PubMed ID: 4206440
    [No Abstract]   [Full Text] [Related]  

  • 6. [Isolation of a strain of M. tuberculosis which is considered to be rifampicin-dependent, from a patient with long-lasted smear positive and culture difficult (SPCD) mycobacteria].
    Nakamura M; Harano Y; Koga T
    Kekkaku; 1990 Sep; 65(9):569-74. PubMed ID: 2122052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro study on cross resistance of rifampin and rifapentine for Mycobacterium tuberculosis].
    Duanmu HJ; Liu YH; Jiang GL; Wang SM; Fu YH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Mar; 28(3):192-4. PubMed ID: 15854417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results and therapeutic consequences of general resistance tests in tuberculosis of the urogenital system (author's transl).
    Gabler A
    Med Klin; 1973 Dec; 68(50):4648-52. PubMed ID: 4131488
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new method of determining the rifampicin resistance of Mycobacterium tuberculosis].
    Reutgen H
    Acta Biol Med Ger; 1972; 28(3):395-409. PubMed ID: 4626094
    [No Abstract]   [Full Text] [Related]  

  • 10. [A new medium for tubercle bacilli culture- 1% hemolyzed blood semiliquid medium (author's transl)].
    Zheng YZ
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1980 Mar; 3(1):21-5. PubMed ID: 6775915
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
    Mkrtchian SV; Ushkin VV
    Antibiotiki; 1971 May; 16(5):472-7. PubMed ID: 5002224
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bacteriostatic effect of rifampicin (Rifampin) on Mycobacterium tuberculosis in vitro].
    Woźniak S; Tomaszkiewicz L; Zierski M
    Gruzlica; 1969 Nov; 37(11):983-9. PubMed ID: 4983868
    [No Abstract]   [Full Text] [Related]  

  • 13. [The sensitivity of tubercle bacilli to rifampicin and determination of active drug serum level by means of vertical diffusion method].
    Strupczewska-Januszowa H
    Gruzlica; 1970; 38(6):497-500. PubMed ID: 4987944
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rifampicin and its sodium salt in experimental tuberculosis of albino mice].
    Pershin GN; Kutchek SN; Zykova TN
    Farmakol Toksikol; 1972; 35(3):342-7. PubMed ID: 4625834
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sensitivity "in vitro" of human tubercular mycobacteria and atypical mycobacteria to rifampicin].
    Mandler F; Garimoldi M
    G Ital Mal Torace; 1969; ():Suppl 2:7-13. PubMed ID: 4982435
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bactericidal effect of rifampicin on resting tubercle bacilli in vitro (author's transl)].
    Kanai K; Kondo E
    Kekkaku; 1979 Feb; 54(2):89-92. PubMed ID: 108446
    [No Abstract]   [Full Text] [Related]  

  • 17. [Rifampicin sensitivity of mycobacteria].
    Daddi G; Lucchesi M; Mancini P; Matzeu M; Rossi P
    Ann Ist Carlo Forlanini; 1969; 29(1):17-28. PubMed ID: 4996680
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mode of action of rifampicin on Mycobacterium tuberculosis].
    Konno K; Oizumi K; Hayashi I; Oka S
    Kekkaku; 1972 Aug; 47(8):255-60. PubMed ID: 4634136
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of antibacterial preparations on growth of Mycobacterium tuberculosis in a model of primary tuberculous infection in tissue culture].
    Kunichan AD; Sokolova GB; Shapatava MN
    Probl Tuberk; 1994; (5):40-3. PubMed ID: 7870726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Critical concentration for definition of rifampicin resistance of tubercle bacilli].
    Tsukamura M
    Kekkaku; 1972 May; 47(5):113-9. PubMed ID: 4625369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.